Kalibra has successfully integrated AHI's biometric scanning technology into the Kalibra platform, further extending its capability for precision health monitoring and enabling purpose-driven health.
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/30/2024 | Buy → Hold | Maxim Group | |
| 1/18/2022 | $11.00 | Buy | Maxim Group |
Kalibra has successfully integrated AHI's biometric scanning technology into the Kalibra platform, further extending its capability for precision health monitoring and enabling purpose-driven health.
Advanced Health Intelligence Ltd (NASDAQ:AHI) (“AHI” or “the Company”) is pleased to inform shareholders that the Company has extended the previously executed Master Services Agreement (“MSA”) with Pharmak Direct, allowing the parties additional time to integrate the solutions, as set out in the terms and conditions of the MSA between AHI and Pharmak Direct. All other terms and conditions have remained the same, and the parties will work together over the 90-day extension to conclude integration and release in accordance with the previously executed MSA.
Advanced Health Intelligence Ltd (formerly Advanced Human Imaging Ltd) (ASX: AHI) (NASDAQ:AHI, ">))) completes the acquisition of Canadian health technology company wellteq Digital Health Inc.This transaction follows the acquisition of South Africa based Vertica Health (Pty) Ltd in August, a biomathematical health risk modelling platform.The 3-company combination creates the only company globally capable of offering biometric health screening, health risk stratification, triage into telehealth and e-health programs from the digital-health-as-a-service platform, using just a smartphone.To reflect the recently acquired technological capabilities, the AHI shareholders approved for the Company's
Highlights AHI enters collaboration with His Excellency Dr Obaid Alketbi.Bin Farhood Group Founders have worked with and within the Government and healthcare needs across the Middle East. Farhood International Business Management Group is a wholly owned subsidiary of Dr O Group (Bin Farhood Group). Bin Farhood Group to introduce AHI to their extensive healthcare and government network. Perth, Australia, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Advanced Health Intelligence Ltd (ASX/NASDAQ: AHI) ("AHI" or the "Company") is pleased to inform shareholders that the Company has entered into a Collaboration Agreement with His Excellency Dr Obaid Alketbi, Bin Farhood International Business Manag
NEW YORK, June 29, 2023 (GLOBE NEWSWIRE) -- Advanced Health Intelligence Ltd (NASDAQ:AHI) ("Advanced Health Intelligence", "AHI" or the "Company") announces today that its planned ratio change of the Company's American Depositary Shares (ADSs) to its non-traded ordinary shares from the previous ratio of one (1) ADS representing seven (7) ordinary shares to the new ratio of one (1) ADS representing twenty-eight (28) ordinary shares shall become effective on June 30, 2023. The ratio change will have the same effect as a reverse split of the existing ADSs of 1 new ADS for every 4 old ADSs. The effective date for the ratio change is June 29, 2023, and the Company's ADSs will continue to be tra
HighlightsAHI - wellteq - Vertica integration completed following their acquisitions in the first half of the 2022/23 Financial Year.AHI to release its Biometric health assessment Software Development Kit ('SDK') and smartphone app.AHI received $4,494,334 in funding and R&D Tax Incentive payments.Update on AHI commercial partners.Highest quarterly revenue of $253,355 for quarter ending 31 March 2023.At quarter end, AHI had a closing cash balance of $175,000. However, since quarter end, AHI has raised additional funding of $2,558,896.South Perth, Western Australia--(Newsfile Corp. - May 1, 2023) - Advanced Health Intelligence Ltd (ASX: AHI) (NASDAQ:AHI) ('AHI' or 'the company'), is pleased t
6-K - Advanced Health Intelligence Ltd (0001815436) (Filer)
6-K - Advanced Health Intelligence Ltd (0001815436) (Filer)
6-K - Advanced Health Intelligence Ltd (0001815436) (Filer)
Maxim Group downgraded Advanced Health Intelligence from Buy to Hold
Maxim Group initiated coverage of Advanced Human Imaging with a rating of Buy and set a new price target of $11.00